FORMULATION DEVELOPMENT, OPTIMIZATION AND EVALUATION OF TIMOLOL ORODISPERSIBLE FILMS FOR ENHANCED THERAPEUTIC PERFORMANCE
International Journal of Drug Delivery Technology · 27.06.2026 · 16 (58s)
DOI: 10.25258/ijddt.16.58s.32 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 27.06.2026. Verfasst von Umang Kumar und 2 weiteren Autor:innen.
Abstract (Originalsprache)
The present study focuses on the formulation and evaluation of Timolol Maleate Orodispersible Films (ODFs) to enhance patient compliance and therapeutic efficacy. Timolol is widely used in the management of glaucoma by reducing intraocular pressure. Orodispersible films were prepared using solvent casting method with polymers such as HPMC and PVA. Various formulations were optimized based on physicochemical properties, disintegration time, drug content, and in-vitro drug release. The optimized formulation showed rapid disintegration, uniform drug distribution, and enhanced drug release profile. The study concludes that ODFs are a promising drug delivery system for Timolol.
Zitieren
APA
Kumar, U., Mamgain, S., & Parashar, T. (2026). FORMULATION DEVELOPMENT, OPTIMIZATION AND EVALUATION OF TIMOLOL ORODISPERSIBLE FILMS FOR ENHANCED THERAPEUTIC PERFORMANCE. International Journal of Drug Delivery Technology, 16(58s). https://doi.org/10.25258/ijddt.16.58s.32
Vancouver
Kumar U, Mamgain S, Parashar T. FORMULATION DEVELOPMENT, OPTIMIZATION AND EVALUATION OF TIMOLOL ORODISPERSIBLE FILMS FOR ENHANCED THERAPEUTIC PERFORMANCE. International Journal of Drug Delivery Technology. 2026;16(58s). doi:10.25258/ijddt.16.58s.32
BibTeX
@article{Kumar2026,
author = {Kumar, Umang and Mamgain, Shilpa and Parashar, Tarun},
title = {FORMULATION DEVELOPMENT, OPTIMIZATION AND EVALUATION OF TIMOLOL ORODISPERSIBLE FILMS FOR ENHANCED THERAPEUTIC PERFORMANCE},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {58s},
doi = {10.25258/ijddt.16.58s.32}
}
EUVIMED